Research Article
Six Candidate Proneural Factor Messenger RNAs for the Differentiation of Neuroendocrine and Non-Neuroendocrine Carcinomas of the Lung
Masunaga A1,2*, Hayashi S1, Omatsu M3, Kunimura T3, Suzuki K1, Uematsu S1, Kitami A1, Oide T2, Miyagi Y4, Hiroshima K2 and Suzuki T11Respiratory Disease Centre, Northern Yokohama Hospital, Showa University, Japan
2Department of Pathology, Yachiyo Medical Centre, Tokyo Women’s Medical University, Japan
3Department of Clinic-Diagnostic Pathology, Northern Yokohama Hospital, Showa University, Japan
4Molecular Pathology & Genetics Division, Kanagawa Cancer Centre Research Institute, Japan
- *Corresponding Author:
- Atsuko Masunaga
Department of Pathology, Yachiyo Medical Centre
Tokyo Women’s Medical University, Ohwada-Shinden 477-96
Yachiyo, Chiba, 276-8524, Japan
Tel: +81474506000
Fax: +8147587047
E-mail: nonkoamesho0324@yahoo.co.jp
Received date: August 17, 2016; Accepted date: September 06, 2016; Published date: September 08, 2016
Citation: Masunaga A, Hayashi S, Omatsu M, Kunimura T, Suzuki K, et al. (2016) Six Candidate Proneural Factor Messenger RNAs for the Differentiation of Neuroendocrine and Non-Neuroendocrine Carcinomas of the Lung. J Clin Exp Pathol 6:292. doi: 10.4172/2161-0681.1000292
Copyright: © 2016 Masunaga A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: Lung neuroendocrine carcinomas, i.e., small cell lung carcinoma (SCLC) and large cell neuroendocrine carcinoma (LCNEC), and non-neuroendocrine carcinomas, e.g. squamous cell carcinoma and adenocarcinoma are both thought to arise from the same endoderm as respiratory epithelium. However, it is not clear how neuroendocrine carcinomas acquire and maintain their neuroendocrine features. To date, 19 proneural factors that function in the development of the fetal neural system and differentiation of neuroendocrine cells of endodermal origin have been identified. In this study, we investigated the specificity of proneural factor expression in SCLC, lung LCNEC, lung squamous cell carcinoma and lung adenocarcinoma.
Methods: RNA was extracted from 3 SCLCs, 3 LCNECs, 10 invasive squamous cell carcinomas and 10 invasive adenocarcinomas. Specific PCR primers were generated for the 19 proneural factors and messenger RNA copy numbers were measured using reverse transcription real time PCR. Differences in expression were then statistically analysed.
Results: Insulinoma-associated protein 1(INSM1) and mammalian achaete-scute homolog (MASH) 1 mRNA was significantly higher in SCLCs than in squamous cell carcinomas. Oligodendrocyte transcription factor (OLIG)1 and mammalian atonal homolog (MATH)2 mRNA levels were significantly lower in SCLCs and squamous cell carcinomas than in adenocarcinomas. OLIG2 mRNA levels were significantly lower in LCNECs than in adenocarcinomas. MATH3 mRNA levels in LCNECs were significantly higher than in both squamous cell carcinomas and adenocarcinomas.
Conclusion: INSM1, MASH1, OLIG1, OLIG2, MATH2 and MATH3 are candidate proneural factors that could potentially differentiate lung neuroendocrine carcinomas from non-neuroendocrine carcinomas. In particular, MATH3 might be an LCNEC-specific factor.